✦ LIBER ✦

A phase I study of bortezomib and temozolomide in patients with advanced solid tumors

✍ Scribed by J. Portnow; P. Frankel; S. Koehler; P. Twardowski; S. Shibata; C. Martel; R. Morgan; M. Cristea; W. Chow; D. Lim; V. Chung; K. Reckamp; L. Leong; T. W. Synold

Publisher: Springer
Year: 2011
Tongue: English
Weight: 384 KB
Volume: 69
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-011-1721-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase I study of bortezomib plus irino

A Phase I study of bortezomib plus irinotecan in patients with advanced solid tumors

✍ David P. Ryan; Bert H. O'Neil; Jeffrey G. Supko; Carlo M. Rocha Lima; E. Claire 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB 👁 2 views

Phase I clinical trial of bortezomib in

Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumors

✍ David P. Ryan; Leonard J. Appleman; Thomas Lynch; Jeffrey G. Supko; Panagiotis F 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

## Abstract ## BACKGROUND. Bortezomib is the first proteasome inhibitor to show preliminary evidence of activity against solid tumors. Findings from preclinical studies prompted a Phase I trial to determine the maximum tolerated dose (MTD) and dose‐limiting toxicities (DLTs) of bortezomib in combi

A phase I pharmacokinetics study of 9-ni

A phase I pharmacokinetics study of 9-nitrocamptothecin in patients with advanced solid tumors

✍ Zhao Yan; Zhongling Zhu; Kai Li; Peng Chen; Liuchun Wang; Chun Huang; Jinhuai Xu 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 209 KB

Phase I study of cetuximab, erlotinib, a

Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors

✍ Chia-Chi Lin; Emiliano Calvo; Kyriakos P. Papadopoulos; Amita Patnaik; John Sara 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 278 KB

A phase I study of Triapine®in combinati

A phase I study of Triapine®in combination with doxorubicin in patients with advanced solid tumors

✍ William R. Schelman; Sherry Morgan-Meadows; Rebecca Marnocha; Fred Lee; Jens Eic 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 364 KB

A dose-finding and pharmacodynamic study

A dose-finding and pharmacodynamic study of bortezomib in combination with weekly paclitaxel in patients with advanced solid tumors

✍ Bhuvaneswari Ramaswamy; Tanios Bekaii-Saab; Larry J. Schaaf; Gregory B. Lesinski 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 224 KB